Fundraising Fox
/People
Sign in

Steve Gillis

Investor

Managing Director at ARCH Venture Partners

Seattle, Washington

Writes $50K – $150M checks · typically $25M

Find your path to Steve

Sign up to see every warm intro you have to Steve

  • Paths you didn't know you had: your email and LinkedIn already hold routes to Steve. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

About

Steve Gillis is an immunologist-turned-VC who founded Immunex and Corixa, helped develop Enbrel, and leverages roles at Takeda and early-stage biotech boards to bridge science and pharma operations.

Contact· self-published, not guessed

Invests in

AI & Machine LearningBiotechDeep TechHardwareHealthtechMedical Devices

Deals · 1

Skylark BioBoard seat

via ARCH Venture Partners · filed Apr 2024 · $40.9M raise

Attribution from SEC filings, press coverage, and firm rosters.

Other disclosed investments

Sources: SEC Form D filings · curated public sources.

Colleagues at ARCH Venture Partners

Ari Nowacek
Partner at ARCH Venture Partners
Ari Nowacek, M.D, Ph.D.
Partner at ARCH Venture Partners
Axel Bouchon
Venture Partner at ARCH Venture Partners
Axel Bouchon, Ph.D.
Venture Partner at ARCH Venture Partners
Brian Cuneo
Senior Partner at ARCH Venture Partners
Carol Suh
Partner at ARCH Venture Partners
Clinton Bybee
Co-founder & Managing Director, Emeritus at ARCH Venture Partners
Corey Ritter
Partner at ARCH Venture Partners

Network1

Dave Maki
Managing Partner at Altitude Ventures Management, Llc

Investors connected to Steve in public investor directories — a warm-intro map.

Frequently asked questions

Who is Steve Gillis?
Steve Gillis is an immunologist-turned-VC who founded Immunex and Corixa, helped develop Enbrel, and leverages roles at Takeda and early-stage biotech boards to bridge science and pharma operations.
Where does Steve Gillis work?
Steve Gillis is Managing Director at ARCH Venture Partners.
What does Steve Gillis invest in?
Steve Gillis invests in AI & Machine Learning, Biotech, Deep Tech, Hardware, Healthtech, Medical Devices.
What check size does Steve Gillis write?
Steve Gillis typically writes checks of $50K – $150M.
What boards does Steve Gillis sit on?
Steve Gillis holds tracked board seats at Basking Biosciences, Skylark Bio.
What companies has Steve Gillis invested in?
Investments tracked here include Allozyne, Basking Biosciences, BE Biopharma, Bitterroot Bio, Carrick Therapeutics, Dispatch Bio, eGenesis, Faraday Pharmaceuticals, Genetix Biotherapeutics Inc., hC Bioscience, HiberCell, ImmusanT, and 13 more.

About this profile. Compiled from public sources — ARCH Venture Partners's own website, regulatory filings and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights